Neoethicals CIA Ltda Pharmaceutical Import Profile — Ecuador (DGFT 2022–2026)

Name: Neoethicals CIA Ltda Pharmaceutical Import Records from India — 4 Products, $1.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Neoethicals CIA Ltda — Pharmaceutical Importer Profile (2026) | 4 Products, $1.6M Trade | TransData Nexus

Neoethicals CIA Ltda

Pharmaceutical Importer · Ecuador · Advanced Antibiotics Focus · $1.6M Total Trade · DGFT Verified

Neoethicals CIA Ltda is a pharmaceutical importer based in Ecuador with a total trade value of $1.6M across 4 products in 4 therapeutic categories. Based on 34 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Neoethicals CIA Ltda sources from 1 verified Indian supplier, with Caplin Point Laboratories Limited accounting for 100.0% of imports.

Neoethicals CIA Ltda — Import Portfolio & Supplier Network

Neoethicals CIA Ltda import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Neoethicals CIA Ltda?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Caplin Point Laboratories Limited	$7.3M	329	100.0%

Neoethicals CIA Ltda sources from 1 verified Indian supplier across 167 distinct formulations. The sourcing is highly concentrated — Caplin Point Laboratories Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Formulation	Value	Ships
Metronidazole intravenous infusion BP	$507.4K	15
Propofol injectable emulsion USP 1%	$309.9K	7
Nitrofurantoin tablets USP 100MG	$302.4K	7
Tamsulosin hydrochloride capsules USP 0.	$270.6K	9
Ibuprofen tablets BP 400MG	$243.8K	9
Propofol injectable emulsion USP 2%	$186.4K	5
Tigecycline for injection USP	$184.0K	5
Levetiracetam tablets USP 1000MG	$150.2K	4
Heparin sodium injection USP 5000 IU ML 5 ML	$150.0K	3
Ketorolac tromethamine injection USP	$139.2K	5
Losartan potassium tablets USP 50MG	$134.7K	4
Ibuprofen tablets BP 800MG	$133.0K	4
Nitrofurantoin oral suspension BP	$132.7K	6
Itraconazole capsules 100MG	$105.2K	3
Dicloxacillin sodium capsules USP 500MG	$100.5K	3

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Nitrofurantoin	Advanced Antibiotics	$650.0K	13	1.9%	2
2	Losartan	Cardiovascular	$550.0K	11	0.2%	17
3	Lactulose	Gastrointestinal	$231.4K	7	1.7%	7
4	Itraconazole	Antifungals	$150.0K	3	0.5%	5

Neoethicals CIA Ltda imports 4 pharmaceutical products across 4 categories into Ecuador totaling $1.6M.

Neoethicals CIA Ltda — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Neoethicals CIA Ltda is a pharmaceutical importer and wholesaler based in Quito, Ecuador. Established on March 14, 2013, the company specializes in the importation and distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. With a workforce of 54 employees as of 2024, Neoethicals plays a significant role in Ecuador's pharmaceutical supply chain, ensuring the availability of essential medications across the country.

The company's primary focus is on sourcing pharmaceutical products from international suppliers, particularly from India. This strategic sourcing approach allows Neoethicals to offer a diverse range of medications to meet the healthcare needs of the Ecuadorian population. By importing finished formulations, Neoethicals contributes to the efficiency and reliability of the pharmaceutical distribution network in Ecuador.

2Distribution Network

Neoethicals CIA Ltda operates from its headquarters in Quito, Pichincha Province, Ecuador. The company maintains a commercial establishment in Guayaquil, Guayas Province, to enhance its distribution capabilities. While specific details about additional warehouse locations and logistics infrastructure are not publicly disclosed, the company's strategic presence in key cities suggests a well-organized distribution network aimed at efficiently serving the Ecuadorian market.

3Industry Role

In Ecuador's pharmaceutical supply chain, Neoethicals CIA Ltda functions primarily as a wholesaler and importer. By sourcing finished pharmaceutical formulations from international suppliers, especially from India, the company ensures a steady supply of essential medications to various stakeholders, including hospitals, pharmacies, and healthcare providers. This role is crucial in maintaining the availability and accessibility of pharmaceutical products throughout the country.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Neoethicals CIA Ltda

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Neoethicals CIA Ltda exhibits a high degree of sourcing concentration, with a significant portion of its pharmaceutical imports originating from a single supplier: Caplin Point Laboratories Limited. This supplier has been responsible for 100% of the company's shipments, amounting to $7.3 million over 329 shipments.

This single-source dependency presents both opportunities and risks. On one hand, a concentrated sourcing strategy can lead to favorable terms and streamlined logistics. On the other hand, it exposes Neoethicals to potential supply chain disruptions if issues arise with the sole supplier. The stability of this relationship is critical, and any disruptions could significantly impact the company's ability to meet market demand.

2Supply Chain Resilience

The resilience of Neoethicals CIA Ltda's supply chain is closely tied to its exclusive relationship with Caplin Point Laboratories Limited. The absence of backup suppliers means that any disruptions in Caplin Point's operations—such as production delays, quality control issues, or logistical challenges—could directly affect Neoethicals' ability to supply medications to the Ecuadorian market.

Additionally, the company's reliance on a single supplier may limit its ability to diversify its product offerings or respond to changes in market demand. To enhance supply chain resilience, Neoethicals could consider establishing relationships with additional suppliers and diversifying its product portfolio.

Importing Pharmaceuticals into Ecuador — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Ecuador

1Regulatory Authority & Framework

In Ecuador, the regulatory authority overseeing pharmaceutical imports is the National Agency for Regulation, Control, and Sanitary Surveillance (ARCSA). ARCSA is responsible for ensuring the safety, efficacy, and quality of pharmaceutical products entering the Ecuadorian market.

Key legislation governing pharmaceutical imports includes the Organic Health Code, which outlines the requirements for the registration, importation, and commercialization of pharmaceutical products. The marketing authorization pathway for Indian generics involves obtaining ARCSA registration, which requires submission of comprehensive documentation, including product dossiers, manufacturing site inspections, and compliance with Good Manufacturing Practice (GMP) standards.

2Import Licensing & GMP

Import licensing requirements in Ecuador stipulate that all pharmaceutical products must be registered with ARCSA before being imported and marketed. This process ensures that imported products meet the necessary safety and quality standards.

Ecuador recognizes GMP certificates from reputable authorities, including the European Union (EU), World Health Organization (WHO), and Pharmaceutical Inspection Co-operation Scheme (PIC/S). Manufacturers from India seeking to export to Ecuador must provide evidence of GMP compliance from these recognized bodies. Additionally, importers like Neoethicals CIA Ltda must hold a valid wholesale distribution authorization issued by ARCSA to legally distribute pharmaceutical products within Ecuador.

Neoethicals CIA Ltda — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Neoethicals CIA Ltda's product category focus on advanced antibiotics, cardiovascular medications, and gastrointestinal treatments aligns with prevalent health concerns in Ecuador. The high import value of nitrofurantoin, losartan, lactulose, and itraconazole indicates a strategic emphasis on addressing these therapeutic areas.

Market demand for these products is driven by the need to manage infectious diseases, hypertension, and gastrointestinal disorders, which are common health issues in the region. By focusing on these categories, Neoethicals ensures that essential medications are accessible to the Ecuadorian population.

2Sourcing Profile

Neoethicals CIA Ltda's sourcing strategy is heavily reliant on generic drug imports, primarily from India. The company's exclusive relationship with Caplin Point Laboratories Limited underscores this approach. The preference for generic formulations allows Neoethicals to offer cost-effective medications to the Ecuadorian market.

India's established reputation for producing high-quality generics that meet international standards makes it a suitable partner for Neoethicals' procurement needs. This sourcing strategy enables the company to maintain a diverse product portfolio while managing costs effectively.

3Market Positioning

Seller's Guide — How to Become a Supplier to Neoethicals CIA Ltda

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to enter the Ecuadorian market by partnering with Neoethicals CIA Ltda. The company's current sourcing pattern, heavily dependent on a single supplier, presents an opportunity for diversification.

Potential gaps in Neoethicals' current sourcing include the need for additional suppliers to mitigate risks associated with single-source dependency and to enhance supply chain resilience. Indian exporters can leverage this opportunity by offering competitive pricing, reliable quality, and consistent supply to meet the demands of the Ecuadorian market.

2Requirements & Qualifications

Indian exporters seeking to supply Neoethicals CIA Ltda and the Ecuadorian market must adhere to several requirements:

Certifications: Evidence of GMP compliance from recognized authorities such as the EU, WHO, or PIC/S.

Quality Standards: Products must meet international quality standards and be free from contaminants.

Frequently Asked Questions — Neoethicals CIA Ltda

What products does Neoethicals CIA Ltda import from India?

Neoethicals CIA Ltda imports 4 pharmaceutical products across 4 categories. Top imports: Nitrofurantoin ($650.0K), Losartan ($550.0K), Lactulose ($231.4K), Itraconazole ($150.0K).

Who supplies pharmaceuticals to Neoethicals CIA Ltda from India?

Neoethicals CIA Ltda sources from 1 verified Indian suppliers. The primary supplier is Caplin Point Laboratories Limited (100.0% of imports, $7.3M).

What is Neoethicals CIA Ltda's total pharmaceutical import value?

Neoethicals CIA Ltda's total pharmaceutical import value from India is $1.6M, based on 34 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Neoethicals CIA Ltda focus on?

Neoethicals CIA Ltda imports across 4 categories. The largest: Advanced Antibiotics (41.1%), Cardiovascular (34.8%), Gastrointestinal (14.6%).

Get Full Neoethicals CIA Ltda Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Neoethicals CIA Ltda

Neoethicals CIA Ltda — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Neoethicals CIA Ltda?

What Formulations Does Neoethicals CIA Ltda Import?

What Products Does Neoethicals CIA Ltda Import?

Top Products by Import Value

Neoethicals CIA Ltda Therapeutic Categories — 4 Specializations